This author correction pertains to a genetic association study linking lysosome-related genes TMEM175, SCARB2 (LIMP-2), and CTSB (cathepsin B) with Parkinson's disease risk across populations.

These genes point to lysosomal dysfunction, a therapeutically actionable pathway and biomarker axis relevant to GBA-related and broader PD biology, but being a correction with no abstract or new experimental data limits immediate translational impact until the original findings are reviewed.